Romvimza 73207-0304-41
Generic: Vimseltinib
- Manufacturer
- Deciphera Pharmaceuticals, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 14, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA219304
Need to source Romvimza? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Vimseltinib | 30 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]
Selected Package
73207-0304-41Selected1 CARTON in 1 CARTON (73207-304-41) / 1 BLISTER PACK in 1 CARTON / 4 CAPSULE in 1 BLISTER PACK
Other packages for this product(1)
1 CARTON in 1 CARTON (73207-304-40) / 1 BLISTER PACK in 1 CARTON / 8 CAPSULE in 1 BLISTER PACK